DrugPatentWatch Database Preview
Alexza Pharms Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for ALEXZA PHARMS, and what generic alternatives to ALEXZA PHARMS drugs are available?
ALEXZA PHARMS has one approved drug.
There are eighteen US patents protecting ALEXZA PHARMS drugs.
There are two hundred and eighteen patent family members on ALEXZA PHARMS drugs in twenty countries and ten supplementary protection certificates in eight countries.
Summary for Alexza Pharms
| International Patents: | 218 |
| US Patents: | 18 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Alexza Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | RX | Yes | Yes | 8,173,107 | Start Trial | Y | Start Trial | |||
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | RX | Yes | Yes | 7,537,009 | Start Trial | Y | Start Trial | |||
| Alexza Pharms | ADASUVE | loxapine | POWDER;INHALATION | 022549-001 | Dec 21, 2012 | RX | Yes | Yes | 8,955,512 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Alexza Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2341392 | Start Trial |
| Germany | 60326713 | Start Trial |
| Austria | 404184 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Alexza Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1389098 | 300609 | Netherlands | Start Trial | PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220 |
| 1389098 | 1390040-2 | Sweden | Start Trial | PRODUCT NAME: LOXAPIN; REG. NO/DATE: EU/1/13/823/001 20130220 |
| 1389098 | C01389098/01 | Switzerland | Start Trial | PRODUCT NAME: LOXAPINUM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 65461 13.12.2016 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
